The overarching goal of our research is to provide a better understanding of how the brain supports perception, action and attention and how these processes interact. Importantly we also investigate how these abilities are affected by aging and brain disease (stroke, neurodegenerative disorders).

 

Ultimately, our work aims to improve clinical practice in brain disease through the application of cutting-edge cognitive neuroscience models and methods [e.g., lesion-symptom mapping, functional magnetic resonance imaging (fMRI), transcranial magnetic stimulation (TMS); motion-tracking] to identify sensitive biomarkers of neurological recovery and test the efficacy of neurorehabilitation methods targeting cognitive deficits.

​

You can find a copy of our lab guide here.

 

Our work has been funded by a number external sources including: National Institutes of Health Research, Medical Research Council, Leverhulme Trust, Stroke Association, Dunhill Medical Trust, BIAL Foundation and British Academy.

 

We are privileged to work wonderful national and international collaborators:

• SIGHT trial team

• Dr. Fraser W. Smith (PSY, UEA, UK)

• Prof. Valerie Pomeroy (HSC, UEA, UK)

• Dr. Allan Clark (MED, UEA, UK)

• Dr. Laura Biggart (PSY, UEA, UK)

• Dr. Laura Manno (PSY, UEA, UK)

• Dr. Christina Carmichael (PSY, UEA, UK)

• Dr. Yingliang Ma (CMP, UEA, UK)

• Dr. George Malcolm (PSY, UEA, UK)

• Dr. Mintao Zhao (PSY, UEA. UK)

• Dr. Catherine Ford (MED, UEA, UK)

• Prof. Robert D. McIntosh (University of Edinburgh, UK)

• Prof. Jon Evans (University of Glasgow, UK)

• Dr. Arran Reader (University of Stirling, UK)

• Prof. Nancy Kanwisher (MIT, USA)

• Prof. Chris Baker (NIMH, USA)

• Prof. Wilma A. Bainbridge (University of Chicago, USA)

• Prof. Vincenzo Romei (University of Bologna, Italy)

• Evolv Rehabilitation Technologies (Bilbao, Spain) - industry partner

• Animorph Co-op